[1]任 琳.雷尼替丁和奥美拉唑治疗浅表性胃炎的效果比较[J].医学信息,2020,33(12):141-142.[doi:10.3969/j.issn.1006-1959.2020.12.044]
　REN Lin.Ranitidine and Omeprazole in the Treatment of Superficial Gastritis[J].Medical Information,2020,33(12):141-142.[doi:10.3969/j.issn.1006-1959.2020.12.044]
点击复制

雷尼替丁和奥美拉唑治疗浅表性胃炎的效果比较()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年12期
页码:
141-142
栏目:
药物与临床
出版日期:
2020-06-15

文章信息/Info

Title:
Ranitidine and Omeprazole in the Treatment of Superficial Gastritis
文章编号:
1006-1959（2020）12-0141-02
作者:
任 琳
（庄河市第二人民医院内科，辽宁 庄河 116413）
Author(s):
REN Lin
(Department of Internal Medicine,Zhuanghe Second People’s Hospital,Zhuanghe 116413,Liaoning,China)
关键词:
雷尼替丁; 奥美拉唑; 浅表性胃炎
Keywords:
Ranitidine; Omeprazole; Superficial gastritis
分类号:
R573.3
DOI:
10.3969/j.issn.1006-1959.2020.12.044
文献标志码:
A
摘要:
目的 比较雷尼替丁和奥美拉唑治疗浅表性胃炎的临床效果。方法 选取2018年6月~2019年6月在我院接受治疗的88例浅表性胃炎患者作为研究对象，采用随机数字表法分为对照组和观察组，各44例。对照组采用雷尼替丁治疗，观察组采用奥美拉唑治疗，比较两组治疗总有效率、临床症状（胃痛、反酸、饱胀、恶心）消失时间、平均疗程及不良反应发生情况。结果 观察组总有效率为95.45%，高于对照组的93.18%，但差异无统计学意义（P＞0.05）；观察组胃痛、反酸、饱胀、恶心消失时间及疗程均短于对照组，差异有统计学意义（P＜0.05）；治疗期间，观察组不良反应发生率为6.81%，低于对照组的9.09%，但差异无统计学意义（P＞0.05）。结论 雷尼替丁和奥美拉唑治疗浅表性胃炎均可获得良好的效果，且无严重不良反应。但奥美拉唑可在短时间内减轻患者症状，起效较快，疗程短，可作为治疗浅表性胃炎的首选药物。
Abstract:
Objective To compare the clinical effects of ranitidine and omeprazole in the treatment of superficial gastritis.Methods A total of 88 patients with superficial gastritis treated in our hospital from June 2018 to June 2019 were selected as the research object. They were divided into a control group and an observation group with a random number table method, with 44 cases in each group. The control group was treated with ranitidine and the observation group was treated with omeprazole. The total treatment efficiency, clinical symptoms (stomach pain, acid reflux, fullness, nausea) disappearance time, average course of treatment and the occurrence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 95.45%, higher than that of the control group of 93.18%, but the difference was not statistically significant (P>0.05); the time of disappearance of gastric pain, acid reflux, fullness, and nausea in the observation group and the duration of treatment were shorter than the control group,the difference was statistically significant (P<0.05); during treatment, the incidence of adverse reactions in the observation group was 6.81%, which was lower than 9.09% in the control group, but the difference was not statistically significant (P>0.05).Conclusion Ranitidine and omeprazole can achieve good results in the treatment of superficial gastritis without serious adverse reactions. However, omeprazole can alleviate the symptoms of patients in a short period of time; it has a faster onset and a shorter course of treatment, and can be used as the first choice for the treatment of superficial gastritis.

参考文献/References:

[1]张菊珍,殷圣虹.奥美拉唑治疗慢性胃炎合并消化性溃疡的疗效[J].中国卫生标准管理,2015,6(33):119-120.[2]戈水根,黎江萍,陈志友,等.奥美拉唑佐治浅表性胃炎92例疗效分析[J].当代医学,2014,31(30):122-123．[3]周本炉.奥美拉唑联合多潘立酮治疗慢性浅表性胃炎临床疗效观察[J].基层医学论坛,2016,20(32):4556－4557．[4]王运杰.慢性浅表性胃炎的治疗方法和治疗效果[J].中外医疗,2015,9(17):31-32.[5]肖俊.慢性浅表性胃炎患者的临床治疗方案[J].中国继续医学教育,2015,7(26):60-61.

相似文献/References:

[1]夏 铭,张正坤,曾海龙,等.四种疗法治疗幽门螺杆菌阳性消化性溃疡疗效分析[J].医学信息,2018,31(11):18.[doi:10.3969/j.issn.1006-1959.2018.11.006]
　XIA Ming,ZHANG Zheng-kun,ZENG Hai-long,et al.Therapeutic Effect of Four Kinds of Therapy on Helicobacter Pylori Positive Peptic Ulcer[J].Medical Information,2018,31(12):18.[doi:10.3969/j.issn.1006-1959.2018.11.006]
[2]陈艳玲.奥美拉唑、兰索拉唑与泮托拉唑治疗胃炎胃溃疡的效果及安全性[J].医学信息,2022,35(10):134.[doi:10.3969/j.issn.1006-1959.2022.10.032]
　CHEN Yan-ling.Effect and Safety of Omeprazole, Lansoprazole and Pantoprazole in the Treatment of Gastritis and Gastric Ulcer[J].Medical Information,2022,35(12):134.[doi:10.3969/j.issn.1006-1959.2022.10.032]
[3]张宏程.磷酸铝凝胶联合奥美拉唑治疗消化性溃疡的临床疗效观察[J].医学信息,2019,32(02):150.[doi:10.3969/j.issn.1006-1959.2019.02.044]
　ZHANG Hong-cheng.Clinical Efficacy of Aluminum Phosphate Gel Combined with Omeprazole in the Treatment of Peptic Ulcer[J].Medical Information,2019,32(12):150.[doi:10.3969/j.issn.1006-1959.2019.02.044]
[4]吕彤观.三联疗法治疗牙周病的临床效果观察[J].医学信息,2018,31(18):129.[doi:10.3969/j.issn.1006-1959.2018.18.041]
　LV Tong-guan.Clinical Observation of Triple Therapy for Periodontosis[J].Medical Information,2018,31(12):129.[doi:10.3969/j.issn.1006-1959.2018.18.041]
[5]高华初.泮托拉唑治疗消化性溃疡合并上消化道出血的临床价值评价[J].医学信息,2018,31(22):153.[doi:10.3969/j.issn.1006-1959.2018.22.045]
　GAO Hua-chu.Clinical Value of Pantoprazole in the Treatment of Peptic Ulcer Complicated with Upper Gastrointestinal Bleeding[J].Medical Information,2018,31(12):153.[doi:10.3969/j.issn.1006-1959.2018.22.045]
[6]高华初.奥美拉唑与西咪替丁治疗应激性胃溃疡的疗效观察[J].医学信息,2018,31(23):136.[doi:10.3969/j.issn.1006-1959.2018.23.039]
　GAO Hua-chu.Efficacy of Omeprazole and Cimetidine in the Treatment of Stress Gastric Ulcer[J].Medical Information,2018,31(12):136.[doi:10.3969/j.issn.1006-1959.2018.23.039]
[7]吴文静.注射用奥美拉唑与注射用艾司奥美拉唑治疗活动期胃溃疡患者的临床效果比较[J].医学信息,2022,35(12):187.[doi:10.3969/j.issn.1006-1959.2022.12.048]
　WU Wen-jing.Effect Comparison of Omeprazole Sodium for Injection and Esomeprazole Sodium Injection in the Treatment of Active Gastric Ulcer Patients[J].Medical Information,2022,35(12):187.[doi:10.3969/j.issn.1006-1959.2022.12.048]
[8]李会颖.奥美拉唑联合多潘立酮治疗哮喘合并胃食管反流病的效果[J].医学信息,2020,33(09):144.[doi:10.3969/j.issn.1006-1959.2020.09.047]
　LI Hui-ying.Effect of Omeprazole Combined with Domperidone on Asthma Combined with Gastroesophageal Reflux Disease[J].Medical Information,2020,33(12):144.[doi:10.3969/j.issn.1006-1959.2020.09.047]
[9]温书鑫.奥美拉唑三联疗法治疗慢性胃溃疡的疗效及对患者胃肠功能及Hp根除率的影响[J].医学信息,2022,35(20):136.[doi:10.3969/j.issn.1006-1959.2022.20.037]
　WEN Shu-xin.Effect of Omeprazole Triple Therapy on Gastrointestinal Function and Hp Eradication Rate in Patients with Chronic Gastric Ulcer[J].Medical Information,2022,35(12):136.[doi:10.3969/j.issn.1006-1959.2022.20.037]
[10]刘小娟.大剂量奥美拉唑治疗消化性溃疡出血的有效性与安全性[J].医学信息,2020,33(17):143.[doi:10.3969/j.issn.1006-1959.2020.17.041]
　LIU Xiao-juan.Efficacy and Safety of High-dose Omeprazole in the Treatment of Peptic Ulcer Bleeding[J].Medical Information,2020,33(12):143.[doi:10.3969/j.issn.1006-1959.2020.17.041]

更新日期/Last Update: 1900-01-01